<html xmlns="http://www.w3.org/1999/xhtml"><head>
        <meta http-equiv="Content-Type" content="text/html; charset=utf-8">
        <meta name="viewport" content="width=device-width, height=device-height, initial-scale=0.5, minimum-scale=0.5, user-scalable=yes, maximum-scale=2.0, target-densitydpi=device-dpi" />
				<meta name="robots" content="all"/>
        <meta name="description" content="description">
        <meta name="keywords" content="">
        <title>Page 82 - MIMS April 2020 E4</title>
<style type="text/css">
<!--
body {
	margin-left: 0px;
	margin-top: 0px;
	margin-right: 0px;
	margin-bottom: 0px;
}
  
#container {margin:50px auto;padding:0px;width:910px;}
#left-button{ width:90px; height:100%;float:left }
#middle{ width:730px; margin:0px; float: left;}
#right-button{ width:90px; float:left;}
html, body, div, ul, li, dl, dt, dd, h1, h2, h3, h4, h5, h6, form, input, dd,select, button, textarea, iframe, table, th, td { margin: 0; padding: 0; }
img { border: 0 none; displayblock}
span,ul,li,image{ padding:0px; margin:0px; list-style:none;}
#top-title{ width:714px; margin-bottom:10px; float:left; padding:0px 8px}
#top-title2{ width:320px;  float:right;}
#content{ width: 730px; float:left;float:left;word-wrap: break-word;}
#content-top{ width:730px; background-image:url(images/top_bg.jpg); height:56px; background-repeat:no-repeat; float:left;}
#content-top1{ width:70%; padding:16px 0px 0px 30px; font-family:Arial, Helvetica, sans-serif; font-size:24px; color:#636363;float:left;}
#content-top2{ width:60px; float:right; padding:25px 30px 0px 0px;font-family:Arial, Helvetica, sans-serif; font-size:11px; color:#2f2f2f; font-weight:bold; text-align:right}
#content-middle{ width:730px; background-image:url(images/middle_bg.jpg); background-repeat:repeat-y;float:left;}
#content-middle1{ width:475px; padding:25px 0px 25px 35px; font-family:Arial, Helvetica, sans-serif; font-size:12px; color:#636363; line-height:150%;float:left;}
#content-middle2{  padding:7px; float:right; margin:25px 35px 0px 0px; border:solid 1px #c8c8c9; background-color:#FFF; text-align:center}
#content-bottom{ width:730px; background-image:url(images/bottom_bg.jpg); background-repeat:no-repeat; height:58px;float:left;}
#content-bottom2{ width:110px; height:42px; margin:0px auto; padding-top:4px;}
#input{ width:58px; height:20px; background-color:#FFF; border:solid 1px #dfdfe0; color:#636363; text-align:center; font-size:11px;}
.font1{ font-family:Arial, Helvetica, sans-serif; font-size:10px; color:#2f2f2f;}
.font1 a:link{
	text-decoration: none;
    color:#2f2f2f;

}
.font1 a:visited{
	text-decoration: none;
    color:#2f2f2f;
	
}
.font1 a:hover{
	color: #2f2f2f;
	text-decoration: underline;

}



.text-container {
padding: 20px;
color: #333;
margin-top: 24px;
line-height: 22px;
border-top-left-radius: 3px;
border-top-right-radius: 3px;
}

.use-as-video {
float: right;
padding-left: 20px;
}
.cc-float-fix:before, .cc-float-fix:after {
content: "";
line-height: 0;
height: 0;
width: 0;
display: block;
visibility: hidden;
}
.use-as-video-img {
cursor: pointer;
position: relative;
width: 320px;
height: 180px;
}
.use-as-video-title {
font-size: 15px;
font-weight: bold;
color: #000000;
padding-bottom: 5px;
}
-->
</style>
<script type="text/javascript">
<!--
function MM_preloadImages() { //v3.0
  var d=document; if(d.images){ if(!d.MM_p) d.MM_p=new Array();
    var i,j=d.MM_p.length,a=MM_preloadImages.arguments; for(i=0; i<a.length; i++)
    if (a[i].indexOf("#")!=0){ d.MM_p[j]=new Image; d.MM_p[j++].src=a[i];}}
}

function MM_swapImgRestore() { //v3.0
  var i,x,a=document.MM_sr; for(i=0;a&&i<a.length&&(x=a[i])&&x.oSrc;i++) x.src=x.oSrc;
}

function MM_findObj(n, d) { //v4.01
  var p,i,x;  if(!d) d=document; if((p=n.indexOf("?"))>0&&parent.frames.length) {
    d=parent.frames[n.substring(p+1)].document; n=n.substring(0,p);}
  if(!(x=d[n])&&d.all) x=d.all[n]; for (i=0;!x&&i<d.forms.length;i++) x=d.forms[i][n];
  for(i=0;!x&&d.layers&&i<d.layers.length;i++) x=MM_findObj(n,d.layers[i].document);
  if(!x && d.getElementById) x=d.getElementById(n); return x;
}

function MM_swapImage() { //v3.0
  var i,j=0,x,a=MM_swapImage.arguments; document.MM_sr=new Array; for(i=0;i<(a.length-2);i+=3)
   if ((x=MM_findObj(a[i]))!=null){document.MM_sr[j++]=x; if(!x.oSrc) x.oSrc=x.src; x.src=a[i+2];}
}
//-->
</script>
</head>

<body onload="MM_preloadImages('images/next2.png','images/previous2.png')">
<div id="container">
<div id="left-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page81.html"><img src="images/previous_big.png" width="90" height="80" /></a></p>
</div>
<div id="middle">
  <div id="top-title"><span class="font1">Basic HTML Version</span>
    <div id="top-title2">
      <table width="100%" border="0" align="right" cellpadding="0" cellspacing="0">
        <tr>
        	<td width="66%"> </td>
          <td width="35%" style="display:none" align="right"><img src="images/content.png" width="19" height="16" /></td>
          <td width="31%" style="display:none" class="font1"><a href="">Table of Contents</a></td>
          <td width="6%"><img src="images/view.png" width="19" height="16" /></td>
          <td width="28%" class="font1"><a href="../../MIMS April 2020 E4.html#p=82">View Full Version</a></td>
        </tr>
      </table>
    </div>
  </div>
  <div id="content">
     <div id="content-top">
        <div id="content-top1">Page 82 - MIMS April 2020 E4</div>
        <div id="content-top2">P. 82</div>
     </div>
     <div id="content-middle">
     	
     	  <div class="text-container">
    <div class="use-as-video cc-float-fix">
      <a style="text-decoration: none;" href="../../MIMS April 2020 E4.html#p=82"><img src="../thumb/82.jpg" /></a>
    </div>

    <p class="use-as-video-title"></p>
    <pre style="white-space:pre-line"><code>Anaesthetics - 2.1.2 / 2.2                                                      2020-04 / 51
       Indications: Narcot.analges.for use in anaesthes. in combinat.with   (S6) FORTE INJ. 33/2.7/0426. 50µg/ml  CARBOCAINE DENTAL INJECTION, AI Pharm Ltd [P/S]
       neurolept.agents, inhalat.narcot., diazepam &/atropine, post-op pain,   Indications: IV admin:   Mepivacaine HCl 54 mg/1,8 ml.
       epidur. anaesth. pain relief.  (1) Prim.agent for induct.& maint.of anaesth.with 100% 0 2  in card.  Indications: Dent.loc.anaesth.
       (S6) INJ. W/2.9/123, X/2.7/260,   surg.assoc.with use of cardiopulm. bypass apparat.  (S4) 3% INJ.SOL G2753.
       701050-003: 100 µg/2 ml, 10x2 ml, R253,30  (2) Analg.adjunct.in maint.of gen.anaesth.in above & surg.proced.  712515-003: 100x1,8 ml, R793,04
       702067-003: 500 µg/10 ml, 5x10 ml, R633,56  requir.endotrach.intub.& ventilat.   (S4) L INJ.SOL 2% G2752
       For further details refer to manufact.prod.lit.  Epidur.admin:   Mepivacaine HCl 36 mg, levonordefrin 0,09 mg/1,8 ml.
       FORTIVA, (Aspen Pharmacare) Pharmacare   (1) Post-op managem.of pain follow.gen.surg., thorac./orthopaed.  Indications: Dent.loc.anaesth.for prolong.proced.
                                                                  712485-007: 100x1,8 ml, R793,04
                                     proced.& Caesarean sect.
       [N/P/S in C]                  (2) Analges.adjunct.to epidur.bupivacaine with/without adrenal.  For further details refer to manufact.prod.lit.
       Remifentanil                  dur.lab. & vagin.deliv.
       Indications: Narcot.analges./adjunct.for use dur. induct./maint.of   703604-001: 10x 5 ml amps, R556,91  LIGNOCAINE HCl FRESENIUS VIALS, Fresenius Kabi [P/S]
       inhalat.anaesthes.dur.surg. proced. includ.card.surg., analges.& aid   For furth.details refer to manufact.prod.lit.  Lignocaine hydrochloride anhydr.
       to sedat.for up to 72  hrs.in mechanic.ventilat.intens. care pts. Safety   Indications: Loc.anaesth.
       & effic.beyond 72 hrs. not est.  PROPOFOL FRESENIUS AMPS & VIALS, Fresenius Kabi [P/S]  (S4) INJ. G2781, G2782.
       (S6) INJ. 42/2.9/0751, 0752, 0753  Propofol.               898666-004: 10 mg/ml, 10x20 ml vials, R107,26
       721296-001: 1 mg/3 ml vial, 5 vials, R474,91  Indications: Induct.& maint.of gen.anaesth., sedat.of ventilat.adult   898674-007: 20 mg/ml, 10x20 ml vials, R177,74
       721297-001: 2 mg/5 ml vial, 5 vials, R949,82  pts.receiv.intens.care for up to 72 hrs.  Dosage: Depend.on area & method of admin. SC/IM admin only
       721299-001: 5 mg/10 ml vial, 5 vials, R2 374,62  (S5) 1% INJ, [P/S] 33/2.1/0077. 10 mg/ml  Contraindications: Hypovolaem., myasth.grav., heart-block/other
       For further details refer to manufact.prod.lit.  867888-008: 5x20 ml amps, R149,49  conduct.disturb., bradycard., card. decompensat./hypotens., unrelat.
       FRESENIUS PROPOVEN 1%, Fresenius Kabi [P/S]  867896-019: 1x50 ml vials, R74,65  to treatable tachyarrhythm.
                                     867918-004: 1x100 ml vials, R149,49
                                                                  Side effects: CNS excitat.follow.by depress.& simultan.CV syst.de-
       Propofol                                                   press., allerg.reacts., drowsin. lassit., amnes., methaemoglobinaem.,
       Indications: Short-act.IV gen.anaesth.agent for induct.& maint.  (S5) 2% INJ, [P/S] 37/2.1/0554. 20 mg/ml  foet. intoxicat. (use dur.labour), tong.& peri-oral numbn.
                                     705686-001: 1x50 ml vials, R173,37
       of gen.anaesth., sedat.of artif. ventil. pts. in ICU for up to 72 hrs.,   Special precautions: Hepat.insuff., card. condits., epilep., imp.resp.
       consc.sedat.for surg.& diagnost.proced.in adults prov.there are   For further details see manufacturers lit.  funct., myasth.grav., not for IV use, unsafe in porphyr.
       adeq. facil.for monit.of haemodyn.& oxygenat. paramet.& if admin.  RAPIFEN, Piramal Crit.Care [N/P/S in C]  Interactions: Incompat.in sol.with amphotericin/ sulfadiazine/
       by qualif.anaesthet.          Alfentanil HCl equiv.to alfentanil.  methohexital sod./cefazolin sod.& phenytoin, clear.reduc.by
       (S5) EMULS.FOR INJ, 41/2.1/1121, 1122, 1123. 10 mg/ml  Indications: Narcot.analg.in gen.anaesth.for both short (bolus inj)   propanol.&cimetid., card. depress.effs.addit.to beta-block./other
       719223-001: 5x20 ml amps, R109,88  & long (bolus,supplem.by increm./ infus) surgic.proced., anaesth.  antiarrhythm. & IV phenytoin, eff.antagon.by hypokalaem. prod.by
       719224-002: 1x50 ml vial, R54,94  induct.agent.            acetazolam./loop diuret.& thiazides, neuromusc.block.activ.of sux-
       719225-002: 1x100 ml vial, R109,88  (S6) INJ. Q/2.7/327. 0,5 mg/ml.
       For further details see manufacturers lit.  759139-008: 5x2 ml amps, R486,51  amethonium poss.competitiv.enhanc.
       HYPNOMIDATE, Piramal Crit.Care [P/S]  For further details refer to product info.  LIGNOCAINE-HCl B BRAUN, B Braun Medical [P/S]
       Etomidate.                    SUBLIMAZE, Piramal Crit.Care [N/P/S in C]  Lignocaine HCl.
                                                                  Indications: Loc.anaesthes.
       Indications: Induct.of gen.anaesth.for short painless proced.eg   Fentanyl citr.equiv.to fentanyl.
       cardio version/uter.curettage. As no analgesic eff.pres.not suitable   Indications: Narcot.analg.supplem.for use in gen. / reg. anaesth.,   (S4) INJ. 2%, 39/4/0437, 20 mg/ml.
                                                                  709418-001: 20x5 ml amps, R73,39
       for mono-anaesthet.           in combin.with neurolept.agents as premed., anaesth.induct.& as
       (S5) INJ. M/2.2/183. 2 mg/ml.  adjunct to gen.& reg. anaesth. maint., as anaesth.agent with O 2   in   Dosage: Loc.anaesthes: SC/IM use: Dos. depend.on area. lnfiltra-
                                                                  tion & field block anaesthes: Use 0,5 to 1% sol. Nerve block an-
       732036-003: 5x10 ml, R869,07  select. high risk pts.undergo.maj.surg
       For further details refer to manufact.prod.lit.  (S6) INJ. B/2.7/1014, Q/2.7/34. 50 µg/ml.  aesthes.: Depend.on which nerves/plexus & fibre type use 1 to 2% sol.
                                                                  Epidur.anaesthes: Determin.by segment.anaesthes.lev.reqd. Vol reqd.
       KETAMINE FRESENIUS VIALS, Fresenius Kabi [P/S]  767158-016: 5x2 ml amps, R365,71  determin.by which nerve fibres to be block. /anaesthes.lev.reqd.& if
       Ketamine as HCl salt.         767166-019: 5x10 ml amps, R1 828,34  adren.used. Max. dly. dos: 300 mg. Act.durat.prolong.by add. adrenaline
       Indications: Anaesth.induct., maint.of gen. anaesth. in combi-  For further details refer to prod.info  Contraindications: Amide type loc.anaesthet. hypersens., heart
       nat.with oxygen.nitrous oxide., Childr.: Managem.minor surg.&   SUFENTA, Piramal Crit.Care [N/P/S in C]  block, sev.card.conduct. disturbs., ac.heart fail., hypovolaem.shock,
       diagnost.proced.              Sufentanil citr.equiv.to sufentanil.  hypotens. unrelat.to treatable tachyarrhythm., myasthen.grav., safey
       (S5) INJ Y/2.1/373, 273, 274.  Indications: IV admin: Analg.adjunct.in maint.of bal.gen.anaesth.  in pregn.& lactat.not est.
       701062-003: 10 mg/ml, 10x20 ml vials, R698,45  in surg.proced.req.endotrach. intubat. & ventilat. Epidur.admin:   Side effects: Allerg.contact dermatit., burn., sting., tendern., ure-
       701057-003: 50 mg/ml, 10x10 ml vials, R897,98  Post-op. managem. of pain follow.gen.surg./thoracic/ or orthopaed.  thrit., CNS stimulat., drowsin., lassit., amnes., CV syst.depress., ar-
       701054-003: 100 mg/ml, 10x10 ml vials, R1 556,84  proced. & Caesarean sect., analges. adjunct to epidur.bupivacaine   rhythm., bradycard., card.arrest, anaphylax., methaemoglobinaem.,
       For further details ref.to manufact.product lit.  with/without adrenal. dur.lab.& vag.deliv.  tong.& perioral regn. numbn.
       MYLAN REMIFENTANIL, Mylan [N/P/S in C]  (S6) INJ. T/2.9/240, 241. 5 µg/ml.  Special precautions: Concom.propanol./ diltiazem /verapamil &
                                                                  cimetidine, childr./elderly & debilitat., liv.dis., poss.precipitat.seiz.in
       Remifentanil                  786624-019: 5x2 ml amps, R390,10  epilept., card.condits., imp.resp.funct.
       Indications: Narcot.analges./adjunct.for use dur. induct./maint.of   786632-003: 5x10 ml amps, R1 950,29  Drug interactions: Anti-arrhythm.agents( eg. mexiletine/tocainide)
       inhalat.anaesthes.dur.surg. proced. incl.card.surg., analges.& sedat.  (S6) FORTE INJ. V/2.9/308. 50 µg/ml.  incr.cardiotox.risk, propanol /diltiazem & verapamil reduc.plasma
       aid for up to 72  hrs.in mechanic.ventilat.intens.care pts. Safety &   Indications: IV admin:  clear., addit. effs.on cardiovasc.& CNS syst., poss.toxic. lev.with ci-
       effic.beyond 72 hrs. not est.  1.   Prim.agent for induct.& maint.of anaesth.with 100% O2 in card.  metidine, addit.card.depress.eff.with ß-block./other anti-arrythm.&
       (S6) POWD.FOR CONC.FOR SOL.FOR INJ./INFUS, 45/2.9/0658,   surg.assoc.with use of cardiopulm. bypass apparatus.  IV phenytoin, hypokalaem.produc.by acetazolamide/loop diuret. &
       0659, 0660                    2.   Analg.adjunct.in maint.of bal.gen.anaesth.in card.surg.assoc.  thiazides antagon.effs.,
       722284-001: 1 mg, 5 vials, R454,34  with use of cardiopulm. bypass apparatus.& surg.proced.req.
       722285-001: 2 mg, 5 vials, R908,68  endotach. intubat.& ventilat.  MACAINE, (AI Crit.Care) AI Ltd [P/S]
       722287-001: 5 mg, 5 vials, R2 271,73  Epidur.admin:        Bupivacaine HCl 5 mg/ml.
       For further details refer to manufact.prod.lit.  1.   Post-op.managem.of pain follow.gen.surg., thoracic/orthopaed.  Indications: Periph.nerve block, caud./epidur. block.
       MYLAN SUFENTANIL, Mylan       2.   proced. & Caesarean sect.  (S4) INJ, J/4/113.
                                       Analges.adjunct to epidur.bupivacaine with/ without adrenal.
                                                                  740292-005: 10x10 ml, R694,01
       Sufentanil citr.equiv.to sufentanil  dur.lab.& vag.deliv.  (S4) INJ.WITH ADRENAL, G2755.
       Indications: IV admin: Analg.adjunct.in maint.of bal.gen.anaesthet.  779695-003: 5x5 ml, R3 665,40  Bupivacaine HCl 5 mg, adrenaline (1:200 000) as bitartrate 5 µg/ml.
       in surg.proced.requir.endotrach. intubat.& ventilat.  For further details refer to manufact.prod.lit.  Indications: Periph.nerve block, caud./epidur. block.
       Epidur.admin: Post-op pain managem.follow. gen. surg./thorac./or-  789682-001: 10x20 ml, R1 422,01
       thopaed.proced. & Caesarean sect., analges.adjunct.to epidur.bupi-  THIOPENTONE SODIUM FRESENIUS,    (S4) SPINAL INJ, U/4/55.
       vacaine with/ without adrenal.dur.labour & vag.deliv.  Fresenius Kabi  Bupivacaine HCl 5 mg/ml.
       (S6) INJ. 41/2.9/0625         Thiopentone sod.             Indications: Spinal anaesth.
       721196-001: 5 µg/ml, 10x2 ml amps, R554,27  Indications: Anaesthes.induct.prior to admin.of anoth. agent/to pro-  789712-008: 10x4 ml, R690,25
       For furth.details refer to manufact.prod.lit.  vide anaesthes.for short proced. assoc.with little pain, promot.light
                                     sleep dur. region.loc.anaesthes.& for quiet.excitem./ contr. convuls.  (S4) SPINAL INJ.WITH DEXTR, U/4/91.
       PHARMA-Q FENTANYL INJECTION,    as in tetanus/ecclamps./status epilept./ cerebr.haemorrh.& poison.  Bupivacaine HCl 5 mg, dextr.anhydr. 72,7 mg/ml.
       Pharma-Q [N/P/S in C]         by convuls. meds. Barbits.are used as diagnost./therapeut.aids in   Indications: Spinal anaesth.
       Fentanyl citrate.             psychiatry i.e. narcoanalys./narcother.  789704-005: 10x4 ml, R701,36
       Indications: Narcot.analges.for use in anaesthes. in combinat.with   (S5) INJ. J/2.3/403. 0,5 g/20 ml  (S4) VIAFLEX 0,1% INFUS.SOL, A40/4/0182
       neurolept./inhalat.anaesthetics, post-op analges.  850829-003: 10x 20 ml, R489,04  Bupivacaine HCl 1 g/1000 ml
       (S6) INJ. 29/2.7/0604, 0605   850829-004: 50x 20 ml, R2 451,63  Indications: Contin.infus.in lumbar epidur. analges. dur.labour, epi-
       703668-001: 500 µg/10 ml, 10x10 ml, R148,08  For further details refer to manufact.prod.lit.  dur.analges.postop pain contr.
       703587-001: 100 µg/2 ml, 10x2 ml, R88,96                   716826-001: 5x200 ml, R1 600,74
       For further details refer to manufact.prod.lit.            For furth.details refer to manufact.prof.info.
       PHARMA-Q SUFENTANIL INJECTION,                             NAROPIN, (Aspen Pharmacare) Pharmacare [P/S]
       Pharma-Q                      2.2    Local anaesthetics    Ropivacaine.
       Sufentanil citr.equiv.to sufentanil                        Indications: For surg.anesthes.as epidur.block, min.nerve block, in-
       Indications: IV admin: Analg.adjunct.in maint.of bal.gen.anaes-  ADCO-ROPIVACAINE (AI Crit Care) AI Ltd [P/S]  filtrat.anaesthes.& maj.nerve block. For ac.pain managem.as contin.
       thet.in surg.proced. requir.endotrach. intubat.& ventilat., post-op   Ropivacaine HCl  epidur. infus. /intermitt.bolus administrat.e.g. post-op/labour pain &
       pain managem.                 Indications: Epidur.block for surg.anaesthes. incl. Caesarean sect.,   minor nerve block/infiltrat.analges., contin. periph.nerve block in-
       Epidur.admin: Post-op pain managem.follow. gen. surg./thorac./  epidur.infus./intermit.bolus admin. for post-op/ labour pain, min.nerve   fus./intermitt.injects. For ac. pain management in paed.as caud.
       orthopaed.proced. & Caesarean sect., analges.adjunct.to epidur.  block & infiltrat. anaesthes.for surg.anaesthes.& ac.pain managem.,   epidur.block., periph.nerve block for per- and postop.pain managem.
       bupivacaine with/ without adrenal.dur.lab.& vag.deliv.  ac. pain managem.in paed.(caud. epidur. block.)  (S4) INJ. 31/4/0124, 31/4/0126, 0127.
       (S6) INJ. 33/2.7/0397, 0398. 5 µg/ml  (S4) INFUS.SOL, 43/4/0525  838624-014: 2 mg/ml, 5x20 ml amps, R323,98
       705980-001: 10 µg/2 ml,10x2 ml amps, R544,59  721550-001: 2 mg/ml, 5x100 ml bag, R744,19  838632-017: 7,5 mg/ml, 5x10 ml amps, R318,24
       705979-001: 50 µg/10 ml 10x10 ml amps, R2 784,24  For furth.details refer to manufact.prod. lit.  838659-012: 10 mg/ml, 5x10 ml amps, R383,32</code></pre>
     	</div>
    
     </div>
     <div id="content-bottom">
       <div id="content-bottom2">
         <table width="110" border="0" cellspacing="0" cellpadding="0">
           <tr>
             <td width="22%" height="44"><a href="page81.html"><img src="images/previous.png" width="26" height="19" id="Image2" onmouseover="MM_swapImage('Image2','','images/previous2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
             <td width="43%">
             	&nbsp;&nbsp;&nbsp;<a href="page77.html">77</a>&nbsp;&nbsp;&nbsp;<a href="page78.html">78</a>&nbsp;&nbsp;&nbsp;<a href="page79.html">79</a>&nbsp;&nbsp;&nbsp;<a href="page80.html">80</a>&nbsp;&nbsp;&nbsp;<a href="page81.html">81</a>&nbsp;&nbsp;&nbsp;<a href="page82.html">82</a>&nbsp;&nbsp;&nbsp;<a href="page83.html">83</a>&nbsp;&nbsp;&nbsp;<a href="page84.html">84</a>&nbsp;&nbsp;&nbsp;<a href="page85.html">85</a>&nbsp;&nbsp;&nbsp;<a href="page86.html">86</a>&nbsp;&nbsp;&nbsp;<a href="page87.html">87</a>
             </td>
             <td width="35%"><a href="page83.html"><img src="images/next.png" width="26" height="19" id="Image1" onmouseover="MM_swapImage('Image1','','images/next2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
           </tr>
         </table>
       </div>
     </div>
  </div>
</div>
<div id="right-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page83.html"><img src="images/next_big.png" width="90" height="80" /></a></p>
</div>


</div>

</body>
</html>
